11.12.2009 • News

Ashland Completes Sale Of Drew Marine

Ashland completed the sale of its global marine services business, known for many years as Drew Marine, to J. F. Lehman & Co. for approximately $120 million before tax. Ashland will use the net proceeds to reduce debt. Ashland and J. F. Lehman & Co. expect to produce a smooth transition with no disruption in customer service or supply. Summarizing the sale, James J. O'Brien, Ashland chairman and CEO, noted, "This transaction furthers our strategy to strengthen our core specialty chemical businesses while reducing our investment in non-core or non-strategic businesses."

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read